A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/12 (2006.01)
Patent
CA 2521217
Methods for the treatment of acute renal failure, multi-organ failure, early dysfunction of kidney transplant, chronic renal failure, organ dysfunction, and wound healing are provided. The methods include delivering a therapeutic amount of hematopoietic stem cells, non-hematopoietic, mesenchymal stem cells, hemangioblasts, and pre-differentiated cells to a patient in need thereof.
L'invention concerne des procédés destinés au traitement de l'insuffisance rénale aiguë, de la défaillance multiviscérale, du dysfonctionnement précoce de la greffe de rein, de l'insuffisance rénale chronique, de la défaillance viscérale et de la cicatrisation. Les procédés de l'invention consistent à administrer une dose thérapeutique de cellules souches hématopoïétiques, de cellules souches non hématopoïétiques, de cellules souches mésenchymateuses, d'hémangioblastes, et de cellules pré-différenciées à un patient nécessitant un tel traitement.
Cassan Maclean
United States Of America Department Of Veteran's Affairs
University Of Utah Research Foundation
LandOfFree
Stem-cell, precursor cell, or target cell-based treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stem-cell, precursor cell, or target cell-based treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stem-cell, precursor cell, or target cell-based treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1932655